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ABSTRACT 
 
Benign  Masseteric  Hypertrophy  is  a  relatively  uncommon  condition  that  can  occur  unilaterally  or 
bilaterally. Pain may be a symptom, but most frequently a clinician is consulted for cosmetic reasons. In 
some cases prominent Exostoses at the angle of the mandible are noted. Although it is tempting to point 
to Malocclusion, Bruxism, clenching, or Temporomandibular joint disorders, the etiology in the majority 
of cases is unclear. Diagnosis is based on awareness of the condition, clinical and radiographic findings, 
and  exclusion  of  more  serious  Pathology  such  as  Benign  and  Malignant  Parotid  Disease, 
Rhabdomyoma, and Lymphangioma. Treatment usually involves resection of a portion of the Masseter 
muscle with or without the underlying bone. 
 
INTRODUCTION 
 
Idiopathic masseter muscle hypertrophy (IMMH) 
was first described by Legg in 1880, reporting on 
the  case  of  a  10-year-old  girl  with  concurrent 
idiopathic  temporalis  muscle  hypertrophy.  The 
masseter  muscle  is  essential  for  adequate 
mastication  and  is  located  laterally  to  the 
mandibular  ramus,  and  thus  plays  an  important 
role in facial esthetics. A hypertrophied masseter 
will  alter  facial lines,  generating  discomfort and 
negative  cosmetic  impacts  for  many  patients  (1, 
2). 
Benign masseteric hypertrophy is a relatively 
uncommon condition that can occur unilaterally or 
bilaterally.  Unilateral- or bilateral hypertrophy of 
the  masseter  muscle  is  characterized  by  an 
increase in the volume of the muscle mass. This 
condition  is  benign,  asymptomatic,  and  must  be 
differentiated  from  parotid  gland  illnesses, 
Odontogenic  problems,  and  rare  neoplasms  of 
muscular tissue. The reasons why patients request 
a medical consultation are predominantly related 
to  aesthetics,  especially  if  the  hypertrophy  is 
unilateral  due  to  a  noticeable  asymmetry  of  the 
lower third of the face (3, 4).  
CASE REPORT 
 
A 25 year-old patient came to Jimma University 
Dental Clinic with complain of unilateral increase 
of the angle of the mandible with the onset of two 
years prior to the visit. 
 
The  patient  explained  the  area  grew slowly 
which has been painless until now. Furthermore, 
he  had  no  history  of  difficulty  in  opening  his 
mouth  and  he  has  also  been  chewing  on  the 
affected side since childhood until he noticed the 
growth.  Also  he  did  not  have  facial  trauma  or 
Temporomandibular joint clicking and he has no 
family history of Masseter Muscle Hypertrophy. 
During Intra and Extra oral physical examination, 
inspection and palpation was done as a result ,firm 
unilateral tissue was detected over the angle of the 
mandible  ,which  became  more  prominent  when 
the  patient  clenched  his  jaws  (Fig.  1a)  but  the 
opening and closing of the jaws were normal. He 
has open bite, crowding and Malocclusion [class II 
division I] during Occlusion (Fig. 1b) and he has 
dental caries on 37. 
 
      
 
1 Department of Dentistry (Oral and Maxillo- Facial surgery sub team), Jimma University            Ethiop J Health Sci.                               Vol. 21, No. 3                       November 2011 
 
   
210 
 
 
 
Figure 1. a) Frontal view showing Mandibular left angle prominence; b) Intra oral view showing crowding 
and open bite.  
 
An  antero-posterior  and  lateral  oblique 
radiography  was  taken  to  rule  out  unilateral 
masseter muscle hypertrophy. The finding showed 
a compensatory hypertrophy in the area of muscle 
insertion due to the increase of the muscle size and 
tension.  Prominence  of  the  mandible  angle  and 
bone spur development was detected (Fig. 2). 
Figure  2.  Antero-posterior  radiograph  showing 
spur  development  in  the  left  angle  of  the 
mandible. 
 
Then, extraction of the lower second molar was 
done  and  muscle  relaxant  was  prescribed 
(Diazepam  5mg  for  five  days)  and  patient 
reassurance was provided accordingly. Finally, the 
patient  was referred to  orthodontic sub-team  for 
treatment  of  malocclusion.  A  written  informed 
consent  was  obtained  for  case  report  and 
disclosure  of  photographs  and  radiography  for 
scientific purposes. 
 
DISCUSSION  
 
The  masseter,  a  thick  quadrate  masticatory 
muscle, arises from the zygomatic arch and inserts 
into the inferior lateral aspect and angle area of the 
mandibular  ramus.  MH  is  an  asymptomatic 
persistent  enlargement  of  one  or  both  masseter 
muscles  resulting  from  a  work  hypertrophy, 
initiated  by  clenching,  bruxing,  or  heavy  gum 
chewing  and  this  occurs  primarily  in  younger 
patients.  In  older  age  groups  with  dental 
deterioration, there is an inability to fully activate 
the masseters and any pre-existing MH tends to 
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recede.  Anatomically,  most  of  the  masseteric 
thickness  is  along  the  inferior  portion  of  the 
mandibular  ramus,  where  the  facial  contour 
normally tapers. With MH, the patient’s face takes 
on a characteristic rectangular configuration (5,6). 
 
Idiopathic hypertrophy of the masseter muscle is a 
rare  disorder  of  unknown  cause.  Some  authors 
associate it with defective teeth, habit of chewing 
gum,  temporo-mandibular  joint  disorder, 
congenital  and  functional  hypertrophies,  and 
emotional disorders (stress and nervousness). This 
case has been chewing on the left side (affected 
side) since his childhood because he believed that 
chewing  on the right  side  is  out of  norm.  Most 
patients complain of the cosmetic change caused 
by  facial  asymmetry,  also  called  square  face, 
however,  symptoms  such  as  trismus,  protrusion 
and bruxism may also occur (5). 
 
Diagnosis  can  be  produced  from  clinical 
examination, directed interview, panoramic x-ray, 
and  muscle  palpation.  This  last  diagnostic  test 
consists of palpating the muscle with the fingers 
while the patient clenches his/her teeth so that the 
muscle  is  more  prominent  during  contraction. 
With the muscle relaxed and the patient’s mouth 
slightly  open,  extra-oral  palpation  using  both 
hands will pinpoint the intramuscular location of 
the  hypertrophy.  In  this  case  during  physical 
examination the enlargement of masseter muscle 
was detected and the antro -posterior x-ray shows 
bone  growth  at  the  angle  of  mandible  on  the 
affected  side.  According  to  Seltzer  and  Wang 
(1987),  CT  and  MRI  scans  produce  excellent 
images  for  the  diagnosis  of  various  masseter 
muscle conditions. In our case, the diagnosis was 
made by palpating the fiber of masseter muscle at 
the insertion especially at the angle of mandible 
during clenching. Antro -posterior x-ray view of 
the patent shows bone growth at the angle of the 
mandible (2). 
 
The  bone  spurs  at  the  mandible  angle  are 
commonly  associated  findings  and  they  can  be 
observed in the anteroposterior radiograph (Fig. 3) 
in  this  case  report.  However,  Bloem  and  Hoof 
stated that approximately 20% of normal people 
have this finding and that it cannot be considered 
as  diagnostic  aid.  Guggenheim  and  Cohen 
reported that bone spurs are caused by periostal 
irritation and new bone deposition responding to 
increased forces exerted by the muscles bundles 
(7).Idiopathic masseter muscle hypertrophy must 
be accurately diagnosed, as it may be mistaken for 
other  diseases.  Among  them  are  unilateral 
compensatory hypertrophy (due to hypotrophy or 
hypoplasia  in  the  contralateral  side),  masseter 
tumor,  salivary  gland  disease,  parotid  tumor, 
parotid  inflammatory  disease,  and  masseter 
muscle  intrinsic  myopathy  (2,7).  Therapy  for 
masseteric  enlargement  is  usually  unnecessary, 
non-surgical  modality  of  treatment  include 
reassurance  tranquilizer  or  muscle  relaxant, 
psychiatric care and injection of very small dose 
of botulin toxin type A (8). 
 
Excision of the internal layer of the masseter 
muscle and reduction of the thickened bone in the 
region  of  the  mandibular  angle  via  intraoral 
approach is the treatment of choice. Complication 
from  surgical  incision  of  master  includes 
Hematoma,  facial  nerve  paralysis,  infection, 
trismus  and  sequelae  from  general  anesthesia 
(9,10).  
 
Injection of botulinum toxin type A in to the 
masseter  muscle  is  also  another  alternative  as  a 
treatment.  Botulinum  toxin  type  A  injection  is 
reported  to  be  safe  and  effective  treatment 
modality in orofacial dystonies, sialorrhea, frey’s 
syndrome,  muscle  hypertrophies,  etc.  Botulinum 
toxin type A, a power full neurotoxin, is produced 
by the anaerobic organism Clostridium botulinum 
.When injected in to muscle it causes interference 
with  the  neurotransmitter  mechanism  producing 
selective  paralysis  and  subsequent  atrophy  of 
muscle (11-16). 
 
In  conclusion,  MMH  is  a  disease  with 
unknown etiology and rare condition. Its diagnosis 
is  mainly  via  clinical,  accompanied  with 
radiographic  examination  as  it  helps  for  the 
differential  diagnosis  against  other  conditions. 
Though  it  has  no  effect  if  left  untreated,  for 
dodging  of  cosmetic  effect  surgical  treatment  is 
applicable.  
 
 
 
 
            Ethiop J Health Sci.                               Vol. 21, No. 3                       November 2011 
 
   
212 
REFERENCES  
 
1. Arthur.  B.  K.  masseter  muscle  hypertrophy,  
AMA  Arch  Derm  Syphilol.  1954;  69(5):558-
562.  
2. Daniel  Z.  R,  Paulo  M.C,  José  L,  Pires  JR,  
Vinicius  R.F,  Karina  K.  Mandelli,  Marcela 
A.C.  Benign  masseter  muscle  hypertrophy  , 
Rev Bras Otorrinolaringol. 2008;74(5): 790-3.  
3.  Rispoli  DZ,  Camargo  PM,  Pires  JL  , 
Fonseca VR, Mandelli KK, Pereira MA. 
Benign masseter muscle hypertrophy, Braz 
J Otorhinolaryngol. 2008; 74(5):790-3. 
4.  Rocco R.A. Masseter muscle hypertrophy: 
Report of case and literature review, Journal 
of  Oral  and  Maxillofacial  Surgery.  1994; 
52(11):1199-1202. 
5.   Waldhart  .E.  benign  hypertrophy  of  the 
masseter  muscles  and  mandibular  angles, 
AMA Arch Surg 1971; 102(2):115-118.  
6.  C.-C.  Yu  et  al.  Botulinum  Toxin  A  for 
Lower  Facial  Contouring:  A  Prospective 
Study, Aesth Plast Surg.  2007 31:445–451. 
7.  Eduardo  K.S,  Marcelo.G,  Marcelo  P.C. 
Masseter  Muscle  Hypertrophy  -  Case 
Report, Braz Dent J 2006; 17(4): 347-350.  
8.  Al-Ahmad  HT,  Al-Qudah  MA.  The 
treatment  of  masseter  hypertrophy  with 
botulinum toxin type A. Saudi Med J. 2006; 
27:397-400. 
9.   Ham  JW.  Masseter  muscle  reduction 
procedure with radiofrequency Coagulation. 
J Oral Maxillofac Surg. 2009; 67:457-63. 
10. R Roncević. Masseter muscle hypertrophy: 
Aetiology  and  therapy,  Journal  of 
Maxillofacial Surgery.  1986;  14: 344-348.  
11. Smyth  AG.  Botulinum  toxin  treatment  of 
bilateral masseteric Hypertrophy, Br J Oral 
Maxillofac Surg. 1994;32: 29-33. 
12.   Moore  AP,  Wood  GD.  The  medical 
management of masseteric hypertrophy with 
botulinum  toxin  types  A,  Br  J  Oral 
Maxillofac Surg. 1994; 32:26-8. 
13.   Maestre-Ferrín  L,  Burguera  JA, 
Peñarrocha-Diago M, Peñarrocha Diago M. 
Oromandibular dystonia: a dental approach, 
Med  Oral  Patol  Oral  Cir  Bucal.  2009; 
15:e25-7. 
14. Luna  Ortiz  K,  Rascon  Ortiz  M,  Sansón 
Riofrio  JA,  VillavicencioValencia  V, 
Mosqueda  Taylor  A.  Control  of  Frey’s        
syndrome in patients treated with botulinum 
toxin  type  A.  Med  Oral  Patol  Oral  Cir 
Bucal. 2007; 12:E79-84. 
15.  Kwon  JS,  Kim  ST,  Jeon  YM,  Choi  JH. 
Effect of botulinum toxin type A injection 
into human masseter muscle on stimulated    
parotid  saliva  flow  rate.  Int  J  Oral 
Maxillofac Surg. 2009; 38:316-20. 
16. Al-Muharraqi  MA,  Fedorowicz  Z,  Al 
Bareeq  J,  Al  Bareeq  R,  Nasser  M. 
Botulinum  toxin for  masseter  hypertrophy. 
Cochrane  Database  Syst  Rev. 
2009;1:CD007510. 
 